Join us at the 2025 Cutting Edge of Transplantation (CEoT) – Transforming Tomorrow: Leading the Way in Organ Transplantation Modernization – from February 27 to March 1 in Scottsdale, AZ. Register today to be part of the future of transplantation.

The Fellow of the American Society of Transplantation (FAST) designation application is now open to all members who meet the eligibility criteria. Don't miss out on joining this prestigious program and be recognized for your contributions to transplantation!

For a limited time, the AST is offering an exclusive membership discount to transplant trainees. We're on a mission to help trainees boost their careers using the AST's benefits.

Through March 31, 2025, trainees can join the AST for just $60. To join with this promotion, you must qualify as a transplant trainee and be approved for membership. To receive the discount, use code TRAINEE2025.

The AST invites members to participate in exclusive Focus Groups at CEoT 2025! These sessions offer a unique opportunity for our industry partners to gather direct feedback from key stakeholders in transplantation – you. By fostering open dialogue, Focus Groups generate valuable insights that help improve services, inform decision-making, and shape future strategies.

The AST is forming a task force on Living Donation Incentives to explore ethical, social, and financial considerations around incentivizing living donation in the United States. Learn more about this opportunity today. 

The AST is pleased to announce its call for nominations for the 2025 Achievement Awards.

Each year, the AST honors its members’ accomplishments and contributions to the field of transplantation through the Achievement Awards. Members are recognized at different levels of their careers with Basic Science Awards, Clinical Science Awards, and Distinguished Career Awards. Nominate a colleague today!

On behalf of the PSECOP and WHCOP, we would like to invite you to participate in a quick survey entitled Gender Identity Knowledge Among Transplant Professionals.

The aim of the survey is to understand providers’ knowledge and experience providing care to LGBTQ+ identifying patients. Providers include all those who participate in the transplant process, including but not limited to advanced care providers (APPs), coordinators, ethicists, nurses, pharmacists, psychologists, physicians, and surgeons.

The survey has been approved by the AST Education Committee. It will take 5-10 minutes to complete.

Thank you in advance for your time and participation.

The AST developed a survey aimed at soliciting your perspectives on legislative and regulatory issues that significantly influence both patient care and professional practice. Our goal is to establish a platform for our membership to share their invaluable ideas and perspectives and actively engage with the Public Policy Committee and AST leadership. We look forward to your input as we navigate the dynamics of our ever-evolving landscape of transplant care and practice.

The goal of this study was to investigate the association between ex vivo lung perfusion (EVLP) use and inpatient hospitalization cost for lung transplantation in a nationwide sample.

Multiple intraoperative hemodynamic parameters are associated with an increased risk of early allograft dysfunction (EAD) following living donor liver transplantation (LDLT); however, there is significant center-to-center variability in terms of which parameters are used. We sought to determine which intraoperative hemodynamic parameters are most predictive of EAD following LDLT.

Currently, there are no standardized guidelines for graft allocation in heart transplants (HTxs), particularly when considering organs from marginal donors and donors after cardiocirculatory arrest. This complexity highlights the need for an effective risk analysis tool for primary graft dysfunction (PGD), a severe complication in HTx. 

Pancreas Transplantation (PT) provides optimal treatment for patients with severe complicated Type 1 Diabetes Mellitus (T1DM). Restoration of beta-cell mass allows return to euglycaemia and insulin independence. We aimed to examine its impact on the secondary complications associated with severe T1DM including diabetic eye disease, neuropathy and cardiovascular disease.